Oxford Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-103,202
| Closed | -$1.47M | – | 1232 |
|
|
2019
Q4 | $1.47M | Buy |
103,202
+90,067
| +686% | +$1.28M | 0.04% | 617 |
|
|
2019
Q3 | $152K | Buy |
+13,135
| New | +$152K | ﹤0.01% | 1598 |
|
|
2018
Q3 | – | Sell |
-28,700
| Closed | -$746K | – | 1927 |
|
|
2018
Q2 | $746K | Sell |
28,700
-41,040
| -59% | -$1.07M | 0.01% | 1180 |
|
|
2018
Q1 | $1.56M | Buy |
69,740
+12,502
| +22% | +$279K | 0.03% | 709 |
|
|
2017
Q4 | $1.21M | Sell |
57,238
-2,530
| -4% | -$53.3K | 0.03% | 842 |
|
|
2017
Q3 | $1.5M | Buy |
59,768
+24,906
| +71% | +$624K | 0.03% | 766 |
|
|
2017
Q2 | $676K | Sell |
34,862
-34,170
| -49% | -$663K | 0.01% | 1019 |
|
|
2017
Q1 | $1.27M | Sell |
69,032
-10,842
| -14% | -$200K | 0.03% | 710 |
|
|
2016
Q4 | $1.51M | Sell |
79,874
-80,801
| -50% | -$1.53M | 0.05% | 389 |
|
|
2016
Q3 | $3.6M | Sell |
160,675
-55,409
| -26% | -$1.24M | 0.11% | 224 |
|
|
2016
Q2 | $3.85M | Buy |
216,084
+8,322
| +4% | +$148K | 0.13% | 211 |
|
|
2016
Q1 | $2.84M | Sell |
207,762
-35,686
| -15% | -$487K | 0.08% | 294 |
|
|
2015
Q4 | $4.75M | Buy |
+243,448
| New | +$4.75M | 0.11% | 194 |
|